Location: Home
  • search
  • go
  • Relate News
  • 1/12/2010WHO warns against boom for elective C-sections in China
  • 1/12/2010Invida Group launches branded dermatological drugs in Asia
  • 1/12/2010Suven secures two product patents in China and Russia
  • 1/12/2010Initial clinical data shows ZADAXIN'S ability to enhance response to H...
  • 1/12/2010Pfizer partners with India's Strides Arcolab to expand generic drug bu...
  • 1/12/2010Public hospital reform "basically" ready and pending State C...
  • 1/11/2010China approves Circoflex for porcine cirovirus disease
  • 1/11/2010Pharmaron Holdings acquires Bridge Labs to become an integrated CRO
  • 1/11/2010Direct-sales to become a new growth area for Harbin Pharma
  • 1/11/2010Japanese drug wholesalers begin to penetrate the Chinese market
  • 1/11/2010Qiagen partners with Wuxi AppTec to support biomarker development in A...
  • 1/11/2010Jiangsu hands out US$1.8M grant for stem cell R&D
  • 1/8/2010MOH announces priorities for health work and public hospital reform in...
  • 1/8/2010Tianjin Pharmaceutical Group fails to close merger talk with Dongsheng...
  • 1/8/20103SBio files CTA application for Feraheme
  • 1/8/2010Study shows China a leader in regenerative medicine research
  • 1/8/2010Top executive at BMP Sunstone resigns
  • 1/8/2010Lundbeck faces EU antitrust probe
  • 1/8/2010Bristish scientists develop vaccine treatment for Leukemia
  • 1/7/2010China Medicines receives US$70M in private placement from OEP
  • 1/7/2010NDRC to halt bulk vitamin C expansion wave in China
  • 1/7/2010CAMS announces phase III trials of its novel macrolide antibiotic
  • 1/7/2010U.S. to target pharma industry in latest foreign corrupt practices act...
  • 1/6/2010New study: antidepressants not effective for mild depression
  • 1/6/2010VCs eye potential growth of the Chinese vaccine market
  • 1/6/2010CDE reports on drug registration evaluation performance in 2009
  • 1/6/2010Essential drug system to be implemented in selected grade II and III h...
  • 1/6/2010Rural cooperative medical scheme covers 94% of rural population
  • 1/6/2010Xinchang Pharma passes USFDA inspection for bulk antimalaria drugs
  • 1/6/2010China Aoxing Pharma completes phase II trials of novel PD drug
  • Page:670/811 Total number of articles:24323: [First][<<] [668] [669] [670] [671] [672] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group